Axogen, Inc. Reports First Quarter 2026 Financial Results
Axogen delivered strong Q1 results with revenue rising 26.6% year-over-year to $61.5 million, driven by double-digit growth across all target markets. The company also shifted to profitability on an adjusted basis with net income of $4.1 million, or $0.07 per share. Management maintained its full-year 2026 guidance, projecting revenue growth of at least 20% to $270 million and expecting to be free cash flow positive for the year. The balance sheet remains robust with $103.6 million in cash and investments following the repayment of the Oberland loan facility.
Key figures
- Revenue
- 61500000
- Guidance
- 2026 revenue at least 20% growth, or $270 million
- Adjusted Eps
- 0.07
- Gross Margin
- 75.2%
- Adjusted Ebitda
- 5700000
- Cash And Investments
- 103600000
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.